Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
EditorialEditorial
Open Access

Advances in the treatment of metastatic prostate cancer in China

Baojun Wang, Zhenhua Liu, Luyao Yang and Xu Zhang
Cancer Biology & Medicine May 2025, 22 (5) 433-438; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0065
Baojun Wang
1Department of Urology, Chinese PLA General Hospital, Beijing 100853, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhenhua Liu
2Value & Implementation, Global Medical & Scientific Affairs, MSD China, Shanghai 200233, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Luyao Yang
2Value & Implementation, Global Medical & Scientific Affairs, MSD China, Shanghai 200233, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xu Zhang
1Department of Urology, Chinese PLA General Hospital, Beijing 100853, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Xu Zhang
  • For correspondence: xzhang{at}foxmail.com
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
Loading

Article Information

vol. 22 no. 5 433-438
DOI 
https://doi.org/10.20892/j.issn.2095-3941.2025.0065

Published By 
Cancer Biology & Medicine
History 
  • Received March 7, 2025
  • Accepted March 31, 2025
  • Published online June 20, 2025.

Article Versions

  • previous version (May 19, 2025 - 06:24).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright: © 2025, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.

Author Information

Funding

  • MSD China

This editorial was funded by MSD China.

PreviousNext
Back to top

In this issue

Cancer Biology & Medicine: 22 (5)
Cancer Biology & Medicine
Vol. 22, Issue 5
15 May 2025
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Advances in the treatment of metastatic prostate cancer in China
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
Advances in the treatment of metastatic prostate cancer in China
Baojun Wang, Zhenhua Liu, Luyao Yang, Xu Zhang
Cancer Biology & Medicine May 2025, 22 (5) 433-438; DOI: 10.20892/j.issn.2095-3941.2025.0065

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Advances in the treatment of metastatic prostate cancer in China
Baojun Wang, Zhenhua Liu, Luyao Yang, Xu Zhang
Cancer Biology & Medicine May 2025, 22 (5) 433-438; DOI: 10.20892/j.issn.2095-3941.2025.0065
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Androgen signaling axis: the primary treatment target
    • Radiopharmaceuticals: a promising future strategy
    • PARP inhibitors: further investigations required for precision treatment
    • Conclusions
    • Conflict of interest statement
    • Author contributions
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Cancer nanomedicine for therapy: emerging strategies and expanding perspectives
  • Balancing global standards and regional nuances in breast cancer care: the role of guidelines, clinical research, precision medicine, and artificial intelligence in advancing quality of care for patients worldwide
  • Advances in TROP2-targeted antibody-drug conjugates for breast cancer therapy: into the new era
Show more Editorial

Similar Articles

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire